Chemotherapy Combination With Local Radiotherapy and rhGM-CSF for Oligometastatic Stage IV NSCLC Patients

NCT03489616 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

BIOLOGICAL: rhGM-CSF
DRUG: Pemetrexed
RADIATION: Local Radiotherapy
DRUG: Single agent

Sponsor

Shandong Cancer Hospital and Institute